この専門家をプロジェクトに採用したいですか? 見積もりを依頼 無料で。
プロフィール詳細
Dr. MOHMMAD I.に依頼
India
I am a PhD-trained Microbiologist with strong expertise in antimicrobial research, microbial assays, and experimental de
プロフィール概要
専門分野
サービス
職務経験
PhD Researcher
CSIR-Central Drug Research Institute
1月 2020 - 8月 2025
Ph.D Scholar
CSIR-Central Drug Research Institute
1月 2020 - 1月 2025 ![]()
学歴
PhD Microbiology and Immunology
Central Drug Research Institute, Lucknow
1月 2020 - 8月 2025
認定資格
出版物
JOURNAL ARTICLE
Mohmmad Imran, Shriya Singh, Mohammad Naiyaz Ahmad, Pradip Malik, Atri Mukhopadhyay, Karan Singh Yadav, Umesh D. Gupta, Madhav N. Mugale, Kalyan Mitra, Kishore K. Srivastava, et al. (2024). Polycationic phosphorous dendrimer potentiates multiple antibiotics against drug-resistant mycobacterial pathogens . Biomedicine & Pharmacotherapy.
Mohmmad Imran, Tanu Garg, Swetarka Das, Shriya Singh, Atri Mukhopadhyay, Umesh D. Gupta, Sidharth Chopra, Arunava Dasgupta(2023). EphH, a unique epoxide hydrolase encoded by Rv3338 is involved in the survival of Mycobacterium tuberculosis under in vitro stress and vacuolar pH-induced changes . Frontiers in Microbiology. 13. Frontiers Media {SA}
Mohmmad Imran, Mohammad Naiyaz Ahmad, Arunava Dasgupta, Preeti Rana, Nanduri Srinivas, Sidharth Chopra (2022). Novel Approaches for the Treatment of Infections Due to Multidrug-Resistant Bacterial Pathogens . Future Medicinal Chemistry.
Mohmmad Imran and Mohammad Naiyaz Ahmad and Arunava Dasgupta and Preeti Rana and Nanduri Srinivas and Sidharth Chopra(2022). Novel approaches for the treatment of infections due to multidrug-resistant bacterial pathogens . Future Medicinal Chemistry. Future Science Ltd
M. Imran, A. Dasgupta, S. Chopra (2021). Suvratoxumab. Monoclonal antibody targeting S. aureus alpha-toxin, Prevention of S. aureus nosocomial pneumonia . Drugs of the Future.